Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Clinical trial NCT06736574 · RECRUITING

Trial details

NCT number: NCT06736574
Sponsor: Cytokinetics
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Heart Failure Heart Failure With Reduced Ejection Fraction

Start date: 2024-12-19
Primary completion: 2027-09-01
Enrollment: 1800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.